Organizers
Richard Mulligan, Sana Biotechnology
Mila Pollock, Cold Spring Harbor Laboratory
Shirley Tilghman, Princeton University
Topics
- The Discovery of Recombinant DNA
- From Genes to the Genome – Drosophila
- Modifying the Genome and its Expression
- From Genes to Human Disease
- From the Human Genome Project to Complex Traits
- Delivering Genes into Humans
- Modalities for Genetic Interventions
- From Cloning to Gene Therapy – the Globin Gene Paradigm
- New Technologies for Genetic Interventions
- The Biotech Industry Creates Therapies
Speakers
Omar Abudayyeh
Noubar Afeyan
David Altshuler
Marisa Bartolomei
David Baltimore
Jean Beggs
Welcome Bender
Frank Bennett
Mario Capecchi
Stanley Cohen
Francis Collins
Angela Creager
Pieter Cullis
Soraya de Chadarevian
Peter Donnelly
Walter Gilbert
David Glover
Jonathan Gootenberg
Scott Gottlieb
Philip Gregory
Frank Grosveld
David Grunwald
James Gusella
Katherine High
Helen Hobbs
Carl June
Katalin Kariko
Daniel Kevles
Narry Kim
Adrian Krainer
Eric Lander
Peter Lobban
Tom Maniatis
John Maragonore
Craig Mello
Janet Mertz
Matthew Meselson
Anthony Monaco
Melissa Moore
Richard Mulligan
Bob Nelsen
Stuart Orkin
Stelios Papadopoulos
Anna Pyle
David Reich
Peter Rigby
Richard Roberts
Jane Rogers
Michael Rosbash
Gerald Rubin
William Rutter
Michel Sadelain
R. Jude Samulski
Phillip Sharp
Allan Spradling
John Stamatoyannopoulos
Kevin Struhl
Sarah Teichmann
Shirley Tilghman
Marc van Montagu
Jonathan Weissman
Michael Wigler
James Wilson
Feng Zhang
Panel Discussions
The Political Acceptance of Recombinant DNA: Dan Kevles
The History of the Human Genome Project: Eric Lander
Recombinant DNA Creates the Biotech Industry: Stelios Papadopoulos